Overview
Watchlist
Equities
Crypto
Soon
Popular
Cookies
Terms of Service
Privacy Policy
Home
© 2025 FYStats 
Home
Equities
NYMXF
Chart

Nymox Pharmaceutical Corp

NYMXF

Jan 1 1970 00:00:00
0.00
0.000.00%
0.00
0.00
0.00
0.00
0.00
93.54M
Chart
Fundamentals
Soon
Sentiment
Soon
Options
Loading...

Recent Filings

2024-08-29
Form 20-F
ID: 0001640334-24-001383
2024-07-18
Form 6-K
ID: 0001640334-24-001139
2024-07-16
Form 6-K
ID: 0001640334-24-001122
2024-05-13
Form 6-K
ID: 0001640334-24-000763
2024-03-28
Form 6-K
ID: 0001640334-24-000510
2023-11-15
Form 6-K
ID: 0001640334-23-002155
2023-11-09
Form 6-K
ID: 0001640334-23-002040
2023-11-06
Form 6-K
ID: 0001640334-23-002021
2023-10-26
Form 6-K
ID: 0001640334-23-001964
2023-09-25
Form 6-K
ID: 0001640334-23-001739

You might find these companies interesting

BZYR
Burzynski Research Institute Inc
In Vitro & In Vivo Diagnostic Substances (2835)
CLDX
Celldex Therapeutics, Inc.
In Vitro & In Vivo Diagnostic Substances (2835)
NTLA
Intellia Therapeutics, Inc.
In Vitro & In Vivo Diagnostic Substances (2835)
MYGN
Myriad Genetics Inc
In Vitro & In Vivo Diagnostic Substances (2835)
BMRA
Biomerica Inc
In Vitro & In Vivo Diagnostic Substances (2835)
ORKA
Oruka Therapeutics, Inc.
In Vitro & In Vivo Diagnostic Substances (2835)
TRIB
Trinity Biotech Plc
In Vitro & In Vivo Diagnostic Substances (2835)
LNTH
Lantheus Holdings, Inc.
In Vitro & In Vivo Diagnostic Substances (2835)
OCX
Oncocyte Corp
In Vitro & In Vivo Diagnostic Substances (2835)
QDEL
Quidelortho Corp
In Vitro & In Vivo Diagnostic Substances (2835)
NAVB
Navidea Biopharmaceuticals, Inc.
In Vitro & In Vivo Diagnostic Substances (2835)
IDXX
Idexx Laboratories Inc /De
In Vitro & In Vivo Diagnostic Substances (2835)
RGPX
Regenerex Pharma, Inc.
Pharmaceutical Preparations (2834)
ONVO
Organovo Holdings, Inc.
Biological Products, (No Diagnostic Substances) (2836)